Prices delayed by at least 15 minutes | Print
Kanabo Group PLC (KNB)
ORD 2.5POpen
0.30p
Previous close
0.30p
Trade high
0.33p
Volume
11,421
Year high
1.10p
Year low
0.15p
Dividend yield
–
Market capitalisation
£1.42 mn
P/E ratio
0.03
ISIN
GB00BYQCS703
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
Kanabo Group PLC is a digital health company committed to transforming patient care through its technology platform and specialized treatment offerings. It is focused on researching, developing, and commercializing regulated medicinal cannabis-derived formulations and therapeutic inhalation devices. Its NHS-approved online telehealth platform, The GP Service, which provides patients with video consultations, online prescriptions, and primary care services. Its segments include Primary Care, which includes telepharma services provided by GPS, and Secondary Care, which includes the development and distribution of cannabis derived medicinal and wellness products. It derives the majority of revenue from Primary Care. Geographically, it operates in the United Kingdom and Israel.